|
|
|
|
|
Legal status
Patent in force
| (51) | INT.CL. | C07K 16/28 | (2006.01) |
| A61P 37/06 | (2006.01) |
| (11) | Number of the document | 3350223 |
| (13) | Kind of document | T |
| (96) | European patent application number | 16774750.0 |
| Date of filing the European patent application | 2016-09-16 | |
| (97) | Date of publication of the European application | 2018-07-25 |
| (45) | Date of publication and mention of the grant of the patent | 2020-06-17 |
| (46) | Date of publication of the claims translation | 2020-10-26 |
| (86) | Number | PCT/US2016/052040 |
| Date | 2016-09-16 |
| (87) | Number | WO 2017/049024 |
| Date | 2017-03-23 |
| (30) | Number | Date | Country code |
| 201562220442 P | 2015-09-18 | US |
| (72) |
POULTON, Lynn, Dorothy, AU
POLLARD, Matthew, AU
DOYLE, Anthony, G., AU
COOKSEY, Bridget, Ann, AU
PANDE, Vanya, AU
CLARKE, Adam, William, AU
|
| (73) |
Cephalon, Inc.,
41 Moores Road, Frazer, Pennsylvania 19355,
US
|
| (74) |
Reda ŽABOLIENĖ,
METIDA, Verslo centras "VERTAS", Gynėjų g. 16, LT-01109 Vilnius,
LT
|
| (54) | Antikūnai, kurie specifiškai rišasi prie TL1A |
| ANTIBODIES THAT SPECIFICALLY BIND TO TL1A |
| Payment date | Validity (years) | Amount | |
| 2025-07-24 | 10 | 231.00 EUR |
| 2026-09-16 |